Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about board meeting

19 Jan 2026 Evaluate
Glenmark Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 to consider and approve the Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2025.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..